Clinical trial
Evaluation of the IB10 Sphingotest PCT+ in a Point-of-Care Setting
NCT04529733 is registered in ClinicalTrials.gov with Nexus DX as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the IB10 Sphingotest PCT+ in a Point-of-Care Setting
- Lead sponsor
- Nexus DX
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 15, 2020
- Completion date
- March 30, 2021
- Enrollment
- 300 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.